These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 317434)

  • 21. [Malignant lymphoma--recent progress in diagnosis and treatment. 2. Application of recent diagnostic analysis. (1). Cellular origin of non-Hodgkin's lymphoma].
    Shimoyama M
    Nihon Naika Gakkai Zasshi; 1983 Oct; 72(10):1306-11. PubMed ID: 6610008
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 25. [The cellular immunological status as a prognostic factor in non-Hodgkin lymphomas].
    García-Puche JL; Pérez-Alférez N; Muñóz E; Garrido F; Osorio C
    Rev Clin Esp; 1975 Jul; 138(2):163-8. PubMed ID: 1080867
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfer factor in Hodgkin's disease.
    Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
    Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. 3. Chronic lymphatic leukaemia.
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):69-77. PubMed ID: 4702206
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical assessment of T and B lymphocyte functions.
    Farnes P
    R I Med J (1976); 1976 Feb; 59(2):51-6, 71. PubMed ID: 1082619
    [No Abstract]   [Full Text] [Related]  

  • 29. Nuclear alterations during lymphocyte transformation: relationship to the heterogeneous morphologic presentations of non-Hodgkin's lymphomas.
    Dardick I; Setterfield G; Hall R; Bladon T; Little J; Kaplan G
    Am J Pathol; 1981 Apr; 103(1):10-20. PubMed ID: 6971576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current tests for the "in vitro" immunologic exploration in man].
    Kenzari M
    Arch Inst Pasteur Tunis; 1979; 56(1-2):39-52. PubMed ID: 121050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of cell mediated immunity.
    Weston WL
    Int J Dermatol; 1975 Dec; 14(10):699-707. PubMed ID: 127750
    [No Abstract]   [Full Text] [Related]  

  • 36. The T lymphocyte-mediated immune reaction in polytrauma.
    Cebulla M; Kühnl P; Frederking K; Konold P; Pannike A
    Prog Clin Biol Res; 1989; 308():517-21. PubMed ID: 2528745
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymphocyte subpopulations in the peripheral blood during polychemotherapy of non-Hodgkin's lymphoma].
    Trepińska E; Burchardt K; Sokołowski K
    Pol Tyg Lek; 1985 Aug; 40(33):932-5. PubMed ID: 3877275
    [No Abstract]   [Full Text] [Related]  

  • 39. [T and b lymphocytes. II. Sequential valuation in the course of leukaemia and lymphoma (author's transl)].
    Pozzi DH; Jamra M; Musatti CC; Tolnai ME; Figueiredo Mendes N
    Sangre (Barc); 1975; 20(3):311-22. PubMed ID: 1081741
    [No Abstract]   [Full Text] [Related]  

  • 40. Depression of cell-mediated immunity during acute infectious mononucleosis.
    Mangi RJ; Niederman JC; Kelleher JE; Dwyer JM; Evans AS; Kantor FS
    N Engl J Med; 1974 Nov; 291(22):1149-53. PubMed ID: 4370990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.